Latest papers

Multiple defects in energy metabolism in Alzheimer's disease.

One-hour postload plasma glucose levels, a predictor of additional risk for diabetes: prevalence, mechanisms, and associated cardiovascular and metabolic risk factors in Hispanics.

MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study.

Nutrigenomics--uncovering dietary signatures in obesity and metabolic diseases.

Combination therapy with nateglinide and vildagliptin improves postprandial metabolic derangements in Zucker fatty rats.

Breaking patterns of disease: early-life clues may predict long-term health.

[Guidelines for the management of nilotinib (Tasigna)-induced side effects in chronic myelogenous leukemia: recommendations of French Intergroup of CML (Fi-LMC group)].

Association between serum uric acid levels and cardiometabolic risk factors among Japanese junior high school students.

Breaking patterns of environmentally influenced disease for health risk reduction: immune perspectives.

Design and validation of a metabolic disorder resequencing microarray (BRUM1).

A toast to your health, one drink at a time.

Nonalcoholic, nonbiliary pancreatitis: cross-sectional imaging spectrum.

Secondary causes of headaches in children: when it isn't a migraine.

Association between capacity of interferon-alpha production and metabolic parameters.

The ACE Insertion Deletion polymorphism relates to dementia by metabolic phenotype, APOEepsilon4, and age of dementia onset.

Stem cell transplantation for neurometabolic and neurodegenerative diseases.

Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry.

Macrophage migration inhibitory factor (MIF): a promising biomarker.

Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial.

Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia.